# BREXAFEMME
> **NDA214900** · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 2021-06-01
## Drug
- **FDA Application Number:** NDA214900
- **Application type:** New Drug Application
- **Brand name:** BREXAFEMME
- **Generic name:** Ibrexafungerp Citrate
- **Active ingredients:** IBREXAFUNGERP CITRATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLAXOSMITHKLINE
- **First approval:** 2021-06-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214900)
---
*MORVS · CC0 1.0*